- Telehealth Visits
- Insurance plan information
Alexis Polanis, NP
Allergy and Immunology- Telehealth Visits
- Insurance plan information
Allergy & Immunology Mission Bay
Alexis Polanis, NP
Allergy and ImmunologyAllergy & Immunology Mission Bay
- Telehealth Visits
- Insurance plan information
On this page
About me
Alexis Polanis is a nurse practitioner who cares for patients with allergies and other immune conditions.
Polanis earned her doctorate in nursing at the University of San Francisco. She completed her bachelor of science in nursing at the University of South Florida.
Education & training
Board certification
- Family Nurse Practitioner, American Academy of Nurse Practitioners
Degree
- DNP, University of San Francisco
My expertise
Specialties
Locations
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%225338%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%225338%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.